7 March 2026
Clinical performance of REAC biomodulation in the treatment of low-grade inflammation
Analysis of the clinical results of the PMCF study on the REAC ACT, CO and MO-IBZ protocols.
News
Published studies, congresses and updates on REAC® Technology and ASMED® devices.
Reserved access
Access to the display of medical devices and information material is reserved for operators in the sector, in compliance with current legislation.
Continuing the navigation I declare to be a professional health worker.
EnterFor information on treatments you can contact the Rinaldi Fontani Institute in Florence.
Go to irf.itLegislative Decree No 46 of 24 February 1997 — Article 21